PSIAC

Literaturverzeichnis


Sandson NB. Am J Psychiatry. Nov 2006; 163(11): 1891-6 Pubmed [2413]
Sandson NB. Psychosomatics. Sep 2005; 46(5): 464-94 Pubmed [3511]
Sandyk R. S Afr Med J. Oct 1982; 62(17): 592 Pubmed [2144]
Sankaranarayanan A. Psychiatr Danub. Dec 2013; 25(4): 419-22 Pubmed [1085]
Sanofi-Aventis Deutschland GmbH: Fachinformation zu Stilnox, Stand September 2014 [4047]
Sanofi-Aventis Deutschland GmbH: Fachinformation zu Ximovan, Stand Februar 2015 [4049]
Santiago F. Contact Dermatitis. Jan 2010; 62(1): 47-53 Pubmed [5138]
Santoro J. Antimicrob Agents Chemother. Jun 1978; 13(6): 951-4 Pubmed [5176]
Santoso B. Int J Clin Pharmacol Ther Toxicol. Mar 1985; 23(3): 134-6 Pubmed [6844]
Sanwald P. Drug Metab Dispos. May 1996; 24(5): 602-9 Pubmed [4571]
Sar TK. Drug Metabol Drug Interact. Jan 2011; 26(4): 191-6 Pubmed [3376]
Saraeva RB. J Clin Pharm Ther. Dec 2007; 32(6): 641-9 Pubmed [309]
Saraga M. Bipolar Disord. Aug 2006; 8(4): 415-7 Pubmed [6338]
Saran BR. Arch Ophthalmol. Sep 1994; 112(9): 1159-65 Pubmed [6752]
Sarganas G. Europace. Jan 2014; 16(1): 101-8 Pubmed [3558]
Sarma GR. Antimicrob Agents Chemother. Nov 1980; 18(5): 661-6 Pubmed [6854]
Sarnquist F, Larson CP. Drug-induced heat stroke. Anestesiology (1973) 39, 348-50 [2054]
Sarnquist F. Anesthesiology. Sep 1973; 39(3): 348-50 Pubmed [658]
Sasaki et al. Q J Med (1988) 67, 309-17 [788]
Sassim N, Grohmann R. Adverse drug reaction with clozapine and simultaneous application of benzodiazepines. Pharmacopsychiatry (1988) 21, 306-7 [1063]
Sassim N. Pharmacopsychiatry. Nov 1988; 21(6): 306-7 Pubmed [1089]
Sastre-Garau et al. Encephale (1993) 19, 351-2 [1041]
Sathia L. AIDS Res Hum Retroviruses. Jul 2008; 24(7): 897-901 Pubmed [7142]
Sato RI. Arch Intern Med. Dec 1984; 144(12): 2413-4 Pubmed [7002]
Sato S. Pharmacol Toxicol. Mar 2000; 86(3): 145-8 Pubmed [2990]
Sattar SP. Ann Pharmacother. Oct 2003; 37(10): 1429-33 Pubmed [3759]
Sauer et al. (2004) J Pharmacol Exp Therap 308: 410-418 [2530]
Saussele T. Clin Pharmacol Ther. Sep 2007; 82(3): 265-74 Pubmed [3010]
Saussine A. Ann Dermatol Venereol. Jun 2009; 136(6-7): 530-5 Pubmed [850]
Savvidaki E. Exp Clin Transplant. Feb 2014; 12(1): 31-6 Pubmed [7287]
Sawant RD. Can J Clin Pharmacol. Jan 2009; 16(1): e78-9 Pubmed [7020]
Saxon AJ. J Clin Psychiatry. Jun 1989; 50(6): 228-9 Pubmed [2448]
Sayadipour A. Eur Spine J. Oct 2012; 21(10): 2070-8 Pubmed, Volltext, Springer [3329]
Sayal KS. Acta Psychiatr Scand. Oct 2000; 102(4): 250-5 Pubmed [1308]
Sayiner A. Transplantation. Nov 1999; 68(9): 1268-71 Pubmed [6847]
Scaglione F. Clin Pharmacokinet. Feb 2013; 52(2): 69-82 Pubmed [257]
Scarsi K. J Int AIDS Soc. Nov 2014; 17(4 Suppl 3): 19484 Pubmed [6342]
Schachter M. Int J Clin Pract. Jul 2003; 57(6): 479-82 Pubmed [3330]
Schaefer M. Curr Drug Abuse Rev. Jun 2008; 1(2): 177-87 Pubmed [3448]
Schaefer M. Pharmacopsychiatry. Jul 2007; 40(4): 149-51 Pubmed [2634]
Schafer JJ. Ann Pharmacother. Jan 2010; 44(1): 145-56 Pubmed [7244]
Schalekamp et al. Arch Intern Med. 2008 Jan 28;168(2):180-5 [997]
Schaller A. Antimicrob Agents Chemother. Aug 2002; 46(8): 2636-9 Pubmed [6804]
Schaller G. Prog Neuropsychopharmacol Biol Psychiatry. Aug 2009; 33(5): 908-9 Pubmed [1179]
Schaller UC. Ophthalmologe. Apr 1999; 96(4): 267-9 Pubmed [6769]
Scharf et al. Curr Ther Res (1990) 48, 516-23 [2324]
Scharfetter J. Neuropsychiatr. Jan 2014; 28(1): 1-5 Pubmed [3730]
Scheen AJ. Clin Pharmacokinet. Apr 2014; 53(4): 295-304 Pubmed [5773]
Scheen AJ. Clin Pharmacokinet. Jan 2007; 46(1): 1-12 Pubmed [2908]
Scheen AJ. Clin Pharmacokinet. Jan 2007; 46(2): 93-108 Pubmed [165]
Scheen AJ. Clin Pharmacokinet. Sep 2010; 49(9): 573-88 Pubmed [5776]
Scheen AJ. Lancet. Nov 2006; 368(9548): 1660-72 Pubmed [2628]
Schellander R. Pharmacology. Jan 2010; 86(4): 203-15 Pubmed [3162]
Schelleman H. Clin Pharmacol Ther. Aug 2010; 88(2): 214-22 Pubmed [5931]
Schelleman H. Clin Pharmacol Ther. Nov 2008; 84(5): 581-8 Pubmed [5901]
Schelleman H. PLoS One. Jan 2011; 6(6): e21447 Pubmed [4773]
Schillevoort I. Eur J Clin Pharmacol. Jul 2001; 57(4): 327-31 Pubmed [1548]
Schippers EF. AIDS. Dec 2000; 14(17): 2794-5 Pubmed [7060]
Schlatter J. Presse Med. Sep 1999; 28(25): 1381-4 Pubmed [6089]
Schlienger RG. Ann Pharmacother. Dec 2000; 34(12): 1402-5 Pubmed [2768]
Schlienger RG. Praxis (Bern 1994). Oct 1996; 85(44): 1407-12 Pubmed [5727]
Schmider J. Biopharm Drug Dispos. Apr 1997; 18(3): 227-40 Pubmed [4506]
Schmidt A. Neuropsychiatr. Dec 2017; 31(4): 172-175 Pubmed [5357]
Schmidt D, Steinhoff BJ, Stefan H, Elger CE, Pregabalin: An efficacious new add-on drug for chronic partial epilepsy, Nervenheilkunde. Vol. 23(8), (pp 471-477), 2004 [2580]
Schmidt D. Nervenarzt. Oct 2000; 71(10): 849-55 Pubmed [2943]
Schmidt et al. Nervenheilkunde. Vol. 23(8), (pp 471-477), 2004 [2550]
Schmidt GA. J Am Board Fam Med. Jul 2007; 20(4): 411-6 Pubmed [4216]
Schmidt LG. Prog Neuropsychopharmacol Biol Psychiatry. Feb 2002; 26(2): 209-17 Pubmed [5567]
Schmutz JL. Ann Dermatol Venereol. Mar 2003; 130(3): 391 Pubmed [5246]
Schneck C. J Clin Psychiatry. Dec 1998; 59(12): 689 Pubmed [2293]
Schneider C. Travel Med Infect Dis. Mar 2013; 11(2): 71-80 Pubmed [5112]
Schoedel KA. Clin Drug Investig. Mar 2012; 32(3): 157-69 Pubmed [2017]
Schoenholtz N Engl J Med 2005 Jan 20;352(3):301-4 [3081]
Schoerlin MP. Clin Pharmacol Ther. Jan 1991; 49(1): 32-8 Pubmed [1915]
Schöller-Gyüre M. Br J Clin Pharmacol. Oct 2008; 66(4): 508-16 Pubmed [6613]
Schöller-Gyüre M. Clin Pharmacokinet. Jan 2009; 48(9): 561-74 Pubmed [7409]
Schöller-Gyüre M. Contraception. Jul 2009; 80(1): 44-52 Pubmed [6612]
Schöller-Gyüre M. J Clin Pharmacol. Feb 2013; 53(2): 202-10 Pubmed [6272]
Schöller-Gyüre M. J Clin Pharmacol. Mar 2008; 48(3): 322-9 Pubmed [3410]
Scholten JN. Clin Infect Dis. Dec 2003; 37(12): 1686-92 Pubmed [6802]
Scholten PC. Antimicrob Agents Chemother. Dec 1998; 42(12): 3266-8 Pubmed [6996]
Schonder KS. Ann Pharmacother. Dec 2003; 37(12): 1793-6 Pubmed [6451]
Schönfelder S. Clin Neuropharmacol. Nov 2011; 34(6): 256-7 Pubmed [2743]
Schönfeldt-Leucona et al (2006) Pharmacopsychiatry 39:152-154 [2009]
Schoretsanitis G. J Clin Psychopharmacol. Dec 2016; 36(6): 554-561 Pubmed [4336]
Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS, De [2070]
Schotte A. Psychopharmacology (Berl). Mar 1996; 124(1-2): 57-73 Pubmed [2071]
Schroder et al. J Pharmacol Exp Ther. 2011 Jan 24 [3156]
Schrold J. Psychopharmacologia. Jan 1972; 23(2): 115-24 Pubmed [6913]
Schrøder H. Pediatr Hematol Oncol. Jul 1994; 11(4): 445-9 Pubmed [2449]
Schulz-Du Bois C. Pharmacopsychiatry. Nov 2008; 41(6): 258-9 Pubmed [6990]
Schumacher JD. Toxicol Appl Pharmacol. Nov 2015; 289(1): 40-7 Pubmed [5273]
Schürks M. Pharmacopsychiatry. Mar 2005; 38(2): 100-2 Pubmed [2894]
Schussler JM. Am J Psychiatry. Mar 2003; 160(3): 589 Pubmed [4806]
Schütz SG. HIV AIDS (Auckl). Sep 2013; 5: 243-51 Pubmed, Volltext, DOI [3807]
Schwab et al. Deutsches Ärzteblatt Jg. 99/Heft 8/22. Februar 2002 [3061]
Schwab M et al, Pharmakogenetik der Zytochrom-P-450-Enzyme,Bedeutung für Wirkungen und Nebenwirkungen von Medikamenten, Deutsches Ärzteblatt,Heft,22.Februar 2002: A 497-504 [3764]
Schwab M et al. Pharmakogenetik der Zytochrom-P-450-Enzyme Dtsch Arztebl 2002; 99: A 497–504 [Heft 8] [3797]
Schwab M et al. Pharmakogenetik der Zytochrom-P-450-Enzyme. Dtsch Arztebl 2002; 99: A 497–504 [Heft 8] [3662]
Schwab M, Marx C, Zanger UM, Eichelbaum M, Pharmakogenetik der Zytochrom-P-450-Enzyme. Bedeutung für Wirkungen und Nebenwirkungen von Medikamenten [2712]